We have studiedthe expression of prostate-specificantigen (P&44 mRNA by reverse transaiptase-polymerase chain reaction in peripheralblood of 25 patients with cancer of the prostate (CAP), four with benign prostatic hyperplasia PI-, two with renal stones, three with other types of cancer, and six healthy male and three female controls. Expression of mRNA specific for a certain tissue in peripheral blood is thought to indicate the presence of circulating cancer cells and metastatic spread of a tumor originating from this tissue. We detected PSA mRNA in 9 of 18 CAP patients with metastatic disease but in none of 7 patients without metastases. Negative results in patients with metastatic disease were associated with successful endocrine therapy and low concentrations of serum PSA, and the correlation between serum concentrations of PSA and the presence of PSA mRNA in peripheral blood was statistically significant. PSA mRNA was not found in patients with BPH, other types of cancer, or in healthy controls. Thus the occurrence of PSA mRNA in peripheral blood is associated with metastatic CAP. 
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Materials and Methods

Patients
We studied 25 patients with CAP ( Orch., orchiectomy; pros., prostatectomy; E, estrogen. Table 2 . f3-Globin primers were devised on the basis of the published sequence (16) . They are located on either side of intron 2 and produce a fragment of 283 bp. The sequences for f3-globin primers were: Gb sense: ACC CAG AGG TI'C ITI' GCG TC; Gb antisense: TCT GAT AGO CAG CCT GCA CT.
RT-PCR
Of total RNA, 10-50 g was usually isolated from 5-10 mL of blood. The genomic band could be eliminated by using shorter cycles, i.e., 95#{176}C for 45 s and 65#{176}C for 45 s. Amplification with the I3-g!obin primers showed that the isolated mRNA was intact (Fig. 3) .
Amplification
of the PSA rather than the hGK-l gene was ascertained by restriction enzyme analysis and by sequencing the PCR product and comparing the sequence to the PSA and human kallikrein sequences in (21) .
Therefore, although
possible, it is not very likely that the RT-PCR method described here would be useful for detection of circulating breast cancer cells.
